参考文献/References:
[1] ZHANG Y G,GUO T M,GUO X,et al. Clinical diagnosis for discogenic low back pain[J]. International Journal of Biological Sciences,2009,5(7):647-658.
[2] 康海龙,古恩鹏,谢海波,等. 盘源性腰痛的诊疗进展[J].中国中医骨伤科杂志,2014,22(12):78-80.
[3] 杨少锋,郭彦涛,宋水燕.督脉盘龙灸法治疗瘀阻督脉型盘源性腰痛的临床研究[J].中国中医骨伤科杂志,2018,26(2):41-44.
[4] 曹春风,王群波,卢旻鹏,等. 椎间盘源性腰痛的诊断和治疗进展[J]. 颈腰痛杂志,2016,37(2):143-146.
[5] 王海莹,丁文元. 肿瘤坏死因子-α在椎间盘细胞凋亡中的作用[J]. 脊柱外科杂志,2015,13(1):56-59.
[6] WANG J,MARKOVA D,ANDERSON D G,et al.TNF-α and IL-1β promote a disintegrin-like and metalloprotease with thrombospondin type Ⅰ motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc[J].The Journal of Biological Chemistry,2011,286(46):39738-39749.
[7] 周桦,卢建华. 独活寄生汤对椎间盘内紊乱兔模型髓核组织中IL-1β及PGE2的影响[J]. 中华中医药杂志,2016,31(2):665-667.
[8] 王礼宁,郑苏阳,马勇,等. 独活寄生汤应用于骨伤科疾病治疗的研究进展[J].中国中医骨伤科杂志,2017,25(39):80-82.
[9] 王志宏,彭胜,雷明盛,等. 杜仲主要生物活性研究进展[J]. 天然药物研究与开发,2013,25(9):1302-1309.
[10] PENG B G. Pathophysiology,diagnosis,and treatment of discogenic low back pain[J]. World Journal of Orthopedics,2013,4(2):42-47.
[11] 胡静,林黎,钱晓萍,等.中药独活及其单体蛇床子素体外抗血管生成的实验研究[J]. 现代肿瘤医学,2013,21(9):1945-1949.
[12] 于鹏霞,喻婉莹,阚伟娟,等. 蛇床子素的抗炎作用及其机制[J]. 时珍国医国药,2012,23(4):866-868.
[13] 杨武斌,王平. 乌头碱药理作用及毒性研究进展[J]. 时珍国医国药,2014,25(2):427-429.
[14] 刘芳,敖丽娟. 核心肌稳定性训练对腰痛康复治疗的意义[J]. 中国康复医学杂志,2017,32(2):231-234.
[15] 董宪传,王莉,杨永菊,等. 脊柱核心稳定肌训练治疗椎间盘源性腰痛的疗效观察[J]. 辽宁中医杂志,2013(3):489-491.
[16] BYDON M,GARZA-RAMOS R D L,MACKI M,et al. Lumbar fusion versus non-operative management for treatment of discogenic low back pain:a systematic review and meta-analysis of randomized controlled trials[J]. Journal of Spinal Disorders & Techniques,2013,27(5):297-304.